EUVIMEDEUVIMED entdecken
Crossref

A potent icaritin derivative ameliorates Parkinson's disease via GPER-mediated mitophagy restoration and dopaminergic neuroprotection

Xiaowen Wang, Xizhen Cao, Meiyun Cai, Ruiyue Zhao, Yangyang Zheng, Mei Zhang, Changlun Shao, Wenfang Chen

Bioorganic Chemistry · 2026-06 · 174 · 109759

DOI: 10.1016/j.bioorg.2026.109759 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioorganic Chemistry, 2026-06. Verfasst von Xiaowen Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and Pathophysiology, Shandong Provincial Key Laboratory of Pathogenesis and Prevention of Brain Disorders, School of Basic M…. Hauptthemen laut MEDLINE: Neuroprotective Agents, Mitophagy, Flavonoids, Receptors, G-Protein-Coupled. Die Arbeit nennt 53 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shandong Province Natural Science Foundation, Ocean University of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Icaritin (ICT), a major prenylated flavone from Epimedium with anti-osteoporosis, anti-cancer, and anti-inflammatory properties, is limited clinically by poor water solubility and low bioavailability. In this study, ICT derivatives were prepared via multi-step chemical reactions and five ICT derivatives (ICTA, ICTB, ICTC, ICTD and ICTE) were successfully synthesized. Compared with ICT, most derivatives exhibited improved solubility and reduced cytotoxicity. Notably, ICTC showed a significant improvement in aqueous solubility (at least 12-fold higher), favorable lower cytotoxicity (at least 2-fold lower at 20 μM), and prominent neuroprotective effects. Mechanistically, in vitro studies revealed that ICTC targets the G protein-coupled estrogen receptor (GPER) to rescue defective mitophagy by restoring MPP+-suppressed expression of mitophagy-related proteins (PINK1, Parkin) and attenuating MPP+-induced accumulation of autophagic substrates (LC3-II, P62). In vivo, intraperitoneal injection of ICTC (0.3-3 mg/kg) effectively protected against MPTP-induced damage to dopaminergic neurons and attenuated neuroinflammation. Molecular docking, pharmacological blockade and studies in GPER knockout mouse models of Parkinson's disease (PD) confirmed that the effects of ICTC depend on GPER. Moreover, intravenous injection of ICTC also provided effective dopaminergic neuron protection, addressing the limitations of oral formulation. Overall, ICTC is a promising prodrug with enhanced solubility that exerts anti-inflammatory and neuroprotective effects in experimental PD by targeting GPER to ameliorate abnormal mitophagy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuroprotective AgentsMitophagyFlavonoidsReceptors, G-Protein-CoupledReceptors, EstrogenParkinson DiseaseAnimalsMiceHumansStructure-Activity RelationshipMolecular StructureDose-Response Relationship, DrugMaleDopaminergic NeuronsMice, Inbred C57BL

Stichwörter der Autor:innen

G protein-coupled estrogen receptorIcaritin derivativesMitophagyNeuroprotectionParkinson's disease

Substanzen

Neuroprotective AgentsFlavonoidsReceptors, G-Protein-CoupledReceptors, EstrogenicaritinGPER1 protein, mouse

Autor:innen und Institutionen

  • Department of Physiology and Pathophysiology, Shandong Provincial Key Laboratory of Pathogenesis and Prevention of Brain Disorders, School of Basic Medicine, Qingdao University, Qingdao 266071, China.
  • Key Laboratory of Marine Drugs, The Ministry of Education of China, School of Medicine and Pharmacy, College of Food Science and Engineering, Ocean University of China, Laboratory for Marine Drugs and Bioproducts, Pilot…
  • Department of Physiology and Pathophysiology, Shandong Provincial Key Laboratory of Pathogenesis and Prevention of Brain Disorders, School of Basic Medicine, Qingdao University, Qingdao 266071, China. Electronic address…

Förderung

  • National Natural Science Foundation of China
  • Shandong Province Natural Science Foundation
  • Ocean University of China
  • Qingdao Postdoctoral Science Foundation

Zitieren

APA

Wang, X., Cao, X., Cai, M., Zhao, R., Zheng, Y., Zhang, M., Shao, C., & Chen, W. (2026). A potent icaritin derivative ameliorates Parkinson's disease via GPER-mediated mitophagy restoration and dopaminergic neuroprotection. Bioorganic Chemistry, 174, 109759. https://doi.org/10.1016/j.bioorg.2026.109759

Vancouver

Wang X, Cao X, Cai M, Zhao R, Zheng Y, Zhang M, et al. A potent icaritin derivative ameliorates Parkinson's disease via GPER-mediated mitophagy restoration and dopaminergic neuroprotection. Bioorganic Chemistry. 2026;174:109759. doi:10.1016/j.bioorg.2026.109759

BibTeX
@article{Wang2026,
  author = {Wang, Xiaowen and Cao, Xizhen and Cai, Meiyun and Zhao, Ruiyue and Zheng, Yangyang and Zhang, Mei and Shao, Changlun and Chen, Wenfang},
  title = {A potent icaritin derivative ameliorates Parkinson's disease via GPER-mediated mitophagy restoration and dopaminergic neuroprotection},
  journal = {Bioorganic Chemistry},
  year = {2026},
  volume = {174},
  pages = {109759},
  doi = {10.1016/j.bioorg.2026.109759}
}
Kostenlos starten →